Barrett esophagus: diagnostic challenges.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Seminars in diagnostic pathology

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.semdp.2014.02.005PMID 24815936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trends in esophageal adenocarcinoma incidence and mortality

  2013cited by this paper
• No Significant Effects of Smoking or Alcohol Consumption on Risk of Barrett’s Esophagus

  2013cited by this paper
• Value of α‐methylacyl‐CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus

  2013cited by this paper
• Endoscopic Mucosal Resection Results in Change of Histologic Diagnosis in Barrett’s Esophagus Patients with Visible and Flat Neoplasia: A Multicenter Cohort Study

  2013cited by this paper
• Prediction of Adenocarcinoma in Esophagectomy Specimens Based Upon Analysis of Preresection Biopsies of Barrett Esophagus With At Least High-Grade Dysplasia: A Comparison of 2 Systems

  2012cited by this paper
• Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

  2012cited by this paper
• Divergent Expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in Dysplasia and Intramucosal Adenocarcinomas With Intestinal and Foveolar Morphology: Is This Evidence of Distinct Gastric and Intestinal Pathways to Carcinogenesis in Barrett Esophagus?

  2012cited by this paper
• Effects of dropping the requirement for goblet cells from the diagnosis of Barrett's esophagus.

  2012cited by this paper
• High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy

  2012cited by this paper
• Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

  2012cited by this paper
• Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

  2011cited by this paper
• MUC2 Is a Highly Specific Marker of Goblet Cell Metaplasia in the Distal Esophagus and Gastroesophageal Junction

  2011cited by this paper
• American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

  2011cited by this paper
• American Gastroenterological Association technical review on the management of Barrett's esophagus.

  2011cited by this paper
• The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma

  2011cited by this paper
• The significance of "indefinite for dysplasia" grading in Barrett metaplasia.

  2011cited by this paper
• Incidence of adenocarcinoma among patients with Barrett's esophagus.

  2011cited by this paper
• Foveolar type dysplasia in Barrett esophagus

  2010cited by this paper
• Nonadenomatous Dysplasia in Barrett Esophagus: A Clinical, Pathologic, and DNA Content Flow Cytometric Study

  2009cited by this paper
• Prevalence of Barrett’s Esophagus in Patients with or without GERD Symptoms: Role of Race, Age, and Gender

  2009cited by this paper
• Effect of Tumor Characteristics and Duplication of the Muscularis Mucosae on the Endoscopic Staging of Superficial Barrett Esophagus-related Neoplasia

  2009cited by this paper
• Metaplastic Esophageal Columnar Epithelium Without Goblet Cells Shows DNA Content Abnormalities Similar to Goblet Cell–Containing Epithelium

  2009cited by this paper
• Multilayered Epithelium in Mucosal Biopsy Specimens From the Gastroesophageal Junction Region is a Histologic Marker of Gastroesophageal Reflux Disease

  2009cited by this paper
• Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma.

  2009cited by this paper
• Radiofrequency ablation in Barrett's esophagus with dysplasia.

  2009cited by this paper
• Definition of Barrett's Esophagus: Time for a Rethink—Is Intestinal Metaplasia Dead?

  2009cited by this paper
• Intestinal Differentiation in Metaplastic, Nongoblet Columnar Epithelium in the Esophagus

  2009cited by this paper
• Muscularis Mucosae Duplication and the Musculo-fibrous Anomaly in Endoscopic Mucosal Resections for Barrett Esophagus: Implications for Staging of Adenocarcinoma

  2008cited by this paper
• DNA Ploidy Abnormalities in Basal and Superficial Regions of the Crypts in Barrett's Esophagus and Associated Neoplastic Lesions

  2008cited by this paper
• Paget Cells in the Esophagus: Assessment of Their Histopathologic Features and Near-universal Association With Underlying Esophageal Adenocarcinoma

  2008cited by this paper
• Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study

  2008cited by this paper
• Histopathology of Barrett’s esophagus after ablation and endoscopic mucosal resection therapy

  2008cited by this paper
• Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.

  2007cited by this paper
• Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk

  2007cited by this paper
• Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies

  2007cited by this paper
• EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy.

  2007cited by this paper
• Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?

  2007cited by this paper
• Morphologic Features are Useful in Distinguishing Barrett Esophagus From Carditis With Intestinal Metaplasia

  2007cited by this paper
• Goblet cell mimickers in esophageal biopsies are not associated with an increased risk for dysplasia.

  2007cited by this paper
• Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

  2007cited by this paper
• Crypt Dysplasia With Surface Maturation: A Clinical, Pathologic, and Molecular Study of a Barrett's Esophagus Cohort

  2006cited by this paper
• The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy

  2006cited by this paper
• Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

  2006cited by this paper
• Detection by scanning electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epithelium

  2005cited by this paper
• Management of Superficial Barrett's Epithelium-Related Neoplasms by Endoscopic Mucosal Resection: Clinicopathologic Analysis of 27 Cases

  2005cited by this paper
• The frequency of Barrett's esophagus in high-risk patients with chronic GERD.

  2005cited by this paper
• Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus.

  2005cited by this paper
• Prevalence of Barrett's esophagus in the general population: an endoscopic study.

  2005cited by this paper
• Intestinal metaplasia at the gastroesophageal junction.

  2004cited by this paper
• Histologic Classification of Patients Based on Mapping Biopsies of the Gastroesophageal Junction

  2003cited by this paper
• Cdx2 as a Marker of Epithelial Intestinal Differentiation in the Esophagus

  2003cited by this paper
• Mucin Core Peptide Expression Can Help Differentiate Barrett's Esophagus From Intestinal Metaplasia of the Stomach

  2003cited by this paper
• p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression

  2002cited by this paper
• Utilization of Cytokeratins 7 and 20 Does Not Differentiate between Barrett's Esophagus and Gastric Cardiac Intestinal Metaplasia

  2002cited by this paper
• Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus

  2002cited by this paper
• p53 expression in low grade dysplasia in Barrett’s esophagus: correlation with interobserver agreement and disease progression

  2002cited by this paper
• American Gastroenterological Association. Our new president--Jon I. Isenberg, M.D.

  2001cited by this paper
• Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

  2001cited by this paper
• Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.

  2001cited by this paper
• Endoscopic Surveillance of Columnar-Lined Esophagus: Frequency of Intestinal Metaplasia Detection and Impact of Antireflux Surgery

  2001cited by this paper
• Prospective evaluation of multilayered epithelium in Barrett's esophagus

  2001cited by this paper
• Phenotype of Barrett's Esophagus and Intestinal Metaplasia of the Distal Esophagus and Gastroesophageal Junction: An Immunohistochemical Study of Cytokeratins 7 and 20, Das-1 and 45MI

  2001cited by this paper
• Endoscopic mapping and surrogate markers for better surveillance in Barrett esophagus. A study of 700 biopsy specimens.

  2000cited by this paper
• Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets

  2000cited by this paper
• The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

  2000cited by this paper
• Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

  2000cited by this paper
• Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

  2000cited by this paper
• Original contributionThe diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression

  2000cited by this paper
• Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.

  1999cited by this paper
• Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

  1998cited by this paper
• Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria

  1998cited by this paper
• Potential application of p53 as an intermediate biomarker in Barrett's esophagus.

  1994cited by this paper
• p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study.

  1993cited by this paper
• Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.

  1992cited by this paper
• Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

  1988cited by this paper
• The spectrum of carcinoma arising in Barrett's esophagus: A clinicopathologic study of 26 patients

  1984cited by this paper
• Barrett's Esophagus: Comparison of Benign and Malignant Cases

  1983cited by this paper
• The histologic spectrum of Barrett's esophagus.

  1976cited by this paper

• Confocal Laser Endomicroscopy: Real-Time Histology at the Fingertips: A Comprehensive Review of Current Applications of Endomicroscopy in Barrett Esophagus, Inflammatory Bowel Disease, and Colorectal Lesions.

  2026cites this paper
• Agrin loss in Barrett's esophagus-related neoplasia and its utility as a diagnostic and predictive biomarker.

  2021cites this paper
• Non‐conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum

  2020cites this paper
• A Meta-Analysis of the Impact of Obesity, Metabolic Syndrome, Insulin Resistance, and Microbiome on the Diagnosis of Barrett’s Esophagus

  2019cites this paper
• Dysplasia discrimination in intestinal-type neoplasia of the esophagus and colon via digital image analysis

  2016cites this paper
• LYN, a Key Gene From Bioinformatics Analysis, Contributes to Development and Progression of Esophageal Adenocarcinoma

  2015cites this paper